Research

The First Live-Attenuated Vaccine Candidate Completely Protects Against Zika Infection in Mice

One shot triggered full immune response and completely prevented mice from Zika virus infection.


By Donna Ramirez | April 15, 2017

The first live-attenuated Zika vaccine still in the development stage completely protected mice against the virus after a single vaccination dose, according to new research from The University of Texas Medical Branch at Galveston and Instituto Evandro Chagas at the Ministry of Health in Brazil. The findings are currently available in Nature Medicine.

While a Zika infection typically results in mild or symptom-free infections in healthy adults and children, the risk of microcephaly and other diseases in the developing fetus is an alarming consequence that has created a worldwide health threat. Pregnant women who are infected with the Zika virus but never display any disease symptoms may still give birth to a baby with microcephaly.

An effective vaccine is urgently needed for women of childbearing age and travelers to areas where the virus has been reported. Since Zika virus could also be sexually transmitted, prevention of men from infection through vaccination could also halt Zika transmission and diseases.

Rapid and promising progress has been made toward a Zika vaccine. These developing vaccines have been made from an inactivated version of the Zika virus or subunits of the virus; these vaccine candidates have been shown effective in mice and nonhuman primates.

“We chose to pursue a vaccine made from live virus that has been sufficiently attenuated, or weakened, to be safe, and is able to illicit robust immune response to protect us from Zika virus infection. Such live-attenuated vaccine has the advantage of single-dose immunization, rapid and strong immune response and potentially long-lived protection,” said UTMB’s Pei-Yong Shi, senior author and the I.H. Kempner professor at the Department of Biochemistry and Molecular Biology. “A successful vaccine requires a fine balance between efficacy and safety – vaccines made from attenuated live viruses generally offer fast and durable immunity, but sometimes with the trade-off of reduced safety, whereas inactivated and subunit viruses often provide enhanced safety but may require several doses initially and periodic boosters. Therefore, a safe live-attenuated vaccine will be ideal in prevention of Zika virus infection, especially in developing countries.”

To create the vaccine, the researchers engineered the Zika virus by deleting one segment of the viral genome. A similar approach has successfully been used to develop a dengue virus vaccine, which is currently in phase three clinical trials.

Shi explained that the data indicate that the vaccine the team is developing has a good balance between safety and efficacy. A single immunization with the vaccine candidate produced strong immune responses and prevented the virus from infecting mice at all.

“Safety is a major hurdle when developing a live-attenuated vaccine. Our Zika vaccine showed promising safety profile in mice when compared with clinically approved live-attenuated vaccines, such as the yellow fever vaccine,” Shi said.

“Vaccines are an important tool for preventing Zika virus transmission and microcephaly,” said Pedro F. C. Vasconcelos, medical virologist and present director of the Evandro Chagas Institute and co-author. “This vaccine, the first live-attenuated vaccine for Zika, will improve the public health efforts to avoid the birth defects and diseases caused by Zika in countries where the virus is commonly found. The initial target of this vaccine is women of childbearing age, their sexual partners and children less than 10 years old.

Other authors include UTMB’s Chao Shan, Antonio Muruato, Huanle Luo, Xuping Xie, Maki Wakamiya, Robert Tesh, Alan Barrett, Tian Wang, Scott Weaver, and Shannan Rossi; Bruno Nunes and Daniele Medeiros who are affiliated with UTMB and the Instituto Evandro Chagas at the Ministry of Health in Brazil.

This work was supported by UTMB, The University of Texas System, the Centers for Disease Control and Prevention, the Pan American Health Organization and the National Institutes of Health.

Tags | Research



Social Posts

Vincent J Pelatari

Vincent J Pelatari

Praying.....

22 mins ago
profile_image

MD Anderson

@MDAndersonNews

@willcarp_ That's wonderful, Will. What a great milestone!

1 hour ago
profile_image

BCMHouston

@bcmhouston

A new partnership between Baylor and MilliporeSigma aims to advance vaccines to thwart neglected diseases. https://t.co/tZRtOkWU3o

1 hour ago
profile_image

Baylor College of Medicine

BaylorCollegeOfMedicine

A new partnership between Baylor and MilliporeSigma aims to advance vaccines to thwart neglected diseases.

1 hour ago
profile_image

Houston Methodist

@MethodistHosp

8.24, 6-8 p.m.: @MethodistHosp West Hospital free seminar on prevention & pain management for neck & back pain https://t.co/0BpY7chBs5

2 hours ago
profile_image

UTHealth

MyUTHealth

Are you ready to SAFELY enjoy the Aug. 21 solar eclipse? In this Texas Medical Center news story, get tips on how to protect your eyes from Dr. Amir Mohsenin, a...

2 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

.@VALebanon surgeon helps Veterans live normal lives https://t.co/UadymrOahK via @ldnews

3 hours ago
profile_image

Memorial Hermann

MemorialHermann

School nurses learn bleeding control techniques and how to help save lives during Stop the Bleed event.

4 hours ago
profile_image

Memorial Hermann

@memorialhermann

School nurses learn bleeding control techniques and how to help save lives. https://t.co/TidILUVpV1

4 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Phoenix VA staff hit the road to serve rural Veterans https://t.co/TGWGFmTaW9 via #VAntagePoint

4 hours ago
profile_image

MD Anderson

@MDAndersonNews

Spinal cord tumor survivor: ?My health, life were in the best possible hands.? https://t.co/wNCvuBaNZo? https://t.co/ZHJLScR8JR

5 hours ago
profile_image

U.S. Department of Veterans Affairs

VeteransAffairs

Today’s #VeteranOfTheDay is Marine Corps Veteran Robert Estrada. Robert served in the Marine Corps for 8 years as an engineer, Marine Corps Martial Arts Progra...

5 hours ago
profile_image

TAMU Health Sciences

@TAMHSC

RT @AggieNetwork: ?The #AggieNetwork is so cool, camaraderie of Aggies is a real and tangible thing ... All my classmates have really ralli?

5 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Today's #VeteranOfTheDay is @USMC Veteran Robert Estrada https://t.co/X9IYtGAMw9 via #VAntagePoint https://t.co/vehLllCxc2

5 hours ago
profile_image

UTHealth

@UTHealth

RT @UTexasSPH: Eric Boerwinkle was featured about his role in a $500 million grant from @nih_nhlbi to study the human genome. https://t.co/?

6 hours ago